SCHEMBL2424372

SCHEMBL2424372

OC(c1cc2ccccc2o1)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.45
HIF1A Q16665 1/20 0.45
KDM4E B2RXH2 2/20 0.43
FLT3 P36888 1/20 0.43
MGLL Q99685 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TYR P14679 1/20 0.42
DAO P14920 1/20 0.42
AKR1B1 P15121 1/20 0.42
HPGD P15428 1/20 0.42
AGXT P21549 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
CYP2A6 P11509 2/20 0.39
LOXL2 Q9Y4K0 1/20 0.39
TSHR P16473 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8253208 0.75 CYP2D6 (0.40) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL28591305 0.75 CYP2D6 (0.57) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL9811903 0.75 CYP2D6 (0.49) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL4047365 0.75 CYP2D6 (0.57) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL23430130 0.74 KDM4E (0.45) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL12281884 0.74 CYP2D6 (0.39) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL24045384 0.73 KDM4E (0.42) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL10362278 0.72 CYP2D6 (0.46) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL14587017 0.72 CYP2D6 (0.54) CYP2D6HIF1AKDM4EFLT3MGLL
SCHEMBL28837140 0.71 CYP2A6 (0.42) CYP2D6HIF1AKDM4EFLT3MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374802-B1 KYNURENINE PRODUCTION INHIBITOR KYOWA HAKKO KIRIN CO LTD (JP) 2014-04-23 EP disclosed
US-8673908-B2 Kynurenine production inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-03-18 US disclosed
EP-2374802-A1 KYNURENINE PRODUCTION INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2011-10-12 EP disclosed
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYOWA KIRIN CO., LTD. (JP) 2011-09-29 US disclosed
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYOWA KIRIN CO., LTD. (JP) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYNU, KMO, IDO1 CYP2D6 120/4885HIF1A 735/4885KDM4E 755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.